Investigation Overview
Mar. 25, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term investors of Amgen, Inc. (NASDAQ:AMGN) shares over potential breaches of fiduciary duties by certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm concerns whether certain Amgen officers and directors breached their fiduci...
You must register (for free) or login to view the entire investigation.